Role of platelet rich plasma therapy in the treatment of alopecia areata and atrophic acne scars

---

Original Article

Author Details : Sumana Manjunath, Jiya Vijaykumar Popat, Deval Nitinbhai Vora, Amisha Ravjibhai Gabani*, Ravindrakumar Vishnubhai Patel

Volume : 10, Issue : 2, Year : 2024

Article Page : 165-170

https://doi.org/10.18231/j.ijced.2024.030

Suggest article by email

Get Permission

---

Abstract

Backgrounds: Alopecia areata and atrophic acne scars are conditions that significantly impact patients' quality of life. Platelet-rich plasma (PRP) therapy has emerged as a promising treatment modality due to its high concentration of growth factors. This study aimed to evaluate the efficacy of PRP in alopecia areata and acne scars.
Materials and Methods: This was a prospective observational study conducted on 50 patients each of alopecia areata and atrophic acne scars treated with intradermal PRP injections at monthly intervals for 6 months. Alopecia areata severity was assessed using a SALT score. Acne scars were graded as per Goodman and Baron's quantitative scar grading system.
Results: In alopecia areata patients, the mean SALT score reduced significantly from 35±6 at baseline to 22±3 at 6 months post-treatment (p<0> Conclusion: PRP therapy showed statistically significant improvement in SALT scores in alopecia areata and acne scar grades over 6 months. It was well-tolerated. PRP can be considered an effective, safe, and economic treatment modality for chronic alopecia areata and atrophic acne scars with sustained benefits.
 

Keywords: PRP, Alopecia areata, Acne scars

How to cite : Manjunath S, Popat J V, Vora D N, Gabani A R, Patel R V, Role of platelet rich plasma therapy in the treatment of alopecia areata and atrophic acne scars. IP Indian J Clin Exp Dermatol 2024;10(2):165-170

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.